Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle ...

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...

Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor.

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

Per the Zacks Consensus Estimate, the company’s revenues for 2025 are expected to increase 10.6%. More on t:slim X2’s Compatibility With FreeStyle Libre 3 Plus ...

Continuous Glucose Monitoring (CGM) devices make it easy to keep your health in check despite seasonal changes, without the ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.